What this study is
This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.
What's being tested
- Smart Watch
Intervention · OTHER
Participants will be asked to wear the smartwatch daily, for at least 12 hours per day during the 12-week study period, with breaks to recharge the watch as needed.
Study details
- Sponsor
- Case Comprehensive Cancer Center
- Conditions
- Osteosarcoma · Metastatic Bone Disease
- Enrolling
- 60 people
- Starts
- 2026-02-12
- Est. completion
- 2026-11
- Design
- Open-label, non-randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Primary sarcoma or metastatic bone disease of the lower extremities or pelvis.
- Undergoing evaluation for (or have recently undergone) non-surgical or surgical intervention.
- Recent history of home ambulation.
You can't join if
- Under 18 years of age at the time of study enrolment
- Inability to comprehend consent form and give informed consent
- No access to a smartphone (iOS or Android) to interface with watch application
- Tattoos located on the skin of the wrist or forearm where the watch will be placed or other skin conditions preventing adequate sensor function
- Amputation or other disease of the arm or skin that prevents wear of a smart-watch device
- Inability to tolerate watch for at least 12 hours per day on at least 80% of days in a four-week period
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openCase Comprehensive Cancer Center, Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Zachary Burke, MD · Contact216-445-9174burkez@ccf.org
- Rowan Barker-Clarke, Post-Doc Fellow · Sub-investigator
Recruiting
Study team
Sponsor
Case Comprehensive Cancer Center
Study ID CASE1725
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.